BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
+6.61%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$4.18B
AUM Growth
+$413M
(+11%)
Cap. Flow
+$304M
Cap. Flow
% of AUM
7.28%
Top 10 Holdings %
Top 10 Hldgs %
6.7%
Holding
1,500
New
123
Increased
567
Reduced
324
Closed
123
Top Buys
| 1 |
NVIDIA
NVDA
|
+$24.2M |
| 2 |
JPMorgan Chase
JPM
|
+$21.2M |
| 3 |
Johnson & Johnson
JNJ
|
+$15.3M |
| 4 |
Tesla
TSLA
|
+$15.2M |
| 5 |
Microsoft
MSFT
|
+$14.9M |
Top Sells
| 1 |
TA
TravelCenters of America LLC
TA
|
+$21.5M |
| 2 |
Permian Resources
PR
|
+$15.3M |
| 3 |
PBF Energy
PBF
|
+$13.5M |
| 4 |
Netflix
NFLX
|
+$12.8M |
| 5 |
Cigna
CI
|
+$12.2M |
Sector Composition
| 1 | Financials | 24.58% |
| 2 | Consumer Discretionary | 12.2% |
| 3 | Technology | 11.89% |
| 4 | Industrials | 11.88% |
| 5 | Healthcare | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Frequency Electronics
FEIM
$314M
| $142K | ﹤0.01% |
21,500
| – | – |
|
|
SBFM
1202
Sunshine Biopharma
SBFM
$6.52M
| $141K | ﹤0.01% |
143
| – | – |
|
1203
Cemtrex
CETX
$4.62M
| $140K | ﹤0.01% |
9
| – | – |
|
|
TBHC
1204
The Brand House Collective, Inc. Common Stock
TBHC
$44.2M
| $140K | ﹤0.01% |
50,000
| – | – |
|
1205
LGL Group
LGL
$35.5M
| $139K | ﹤0.01% |
29,200
| – | – |
|
1206
Q32 Bio
QTTB
$21.6M
| $137K | ﹤0.01% |
8,617
-4,166
| -33% | -$66.4K |
|
1207
Exagen
XGN
$215M
| $137K | ﹤0.01% |
47,300
| – | – |
|
1208
Solid Biosciences
SLDB
$391M
| $137K | ﹤0.01% |
26,057
-8,629
| -25% | -$45.2K |
|
1209
Neuronetics
STIM
$239M
| $135K | ﹤0.01% |
63,005
-80,000
| -56% | -$172K |
|
1210
Douglas Elliman
DOUG
$239M
| $135K | ﹤0.01% |
60,600
-344,924
| -85% | -$766K |
|
|
KRON
1211
DELISTED
Kronos Bio
KRON
| $134K | ﹤0.01% |
77,800
-70,610
| -48% | -$121K |
|
1212
ARS Pharmaceuticals
SPRY
$1.01B
| $134K | ﹤0.01% |
19,944
| – | – |
|
1213
Magyar Bancorp
MGYR
$112M
| $130K | ﹤0.01% |
12,579
| – | – |
|
1214
Bolt Biotherapeutics
BOLT
$9.69M
| $130K | ﹤0.01% |
5,060
+1,300
| +35% | +$33.3K |
|
1215
Serina Therapeutics
SER
$51.7M
| $129K | ﹤0.01% |
4,116
-711
| -15% | -$22.3K |
|
1216
Precision BioSciences
DTIL
$60.5M
| $129K | ﹤0.01% |
8,180
-2,500
| -23% | -$39.5K |
|
1217
Sensei Biotherapeutics
SNSE
$10.7M
| $129K | ﹤0.01% |
5,645
| – | – |
|
|
UBX
1218
DELISTED
Unity Biotechnology
UBX
| $128K | ﹤0.01% |
50,000
| – | – |
|
1219
Grove Collaborative
GROV
$62.7M
| $127K | ﹤0.01% |
+72,025
| New | +$127K |
|
1220
Aware
AWRE
$58.6M
| $127K | ﹤0.01% |
80,679
-50,000
| -38% | -$79K |
|
1221
ReposiTrak
TRAK
$311M
| $127K | ﹤0.01% |
+12,627
| New | +$127K |
|
1222
TScan Therapeutics
TCRX
$103M
| $125K | ﹤0.01% |
50,000
-65,000
| -57% | -$163K |
|
|
SYRS
1223
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $124K | ﹤0.01% |
39,500
-10,000
| -20% | -$31.5K |
|
|
VIA
1224
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $123K | ﹤0.01% |
+17,740
| New | +$123K |
|
1225
Lipocine
LPCN
$15.9M
| $123K | ﹤0.01% |
24,665
| – | – |
|